Persistence of Mycoplasma genitalium following azithromycin therapy - Wikidata - awgldk - TriplyDB

Persistence of Mycoplasma genitalium following azithromycin therapy

Persistence of Mycoplasma genitalium following azithromycin therapy

http://www.wikidata.org/entity/Q33382111

about

Mycoplasma genitalium: an emerging cause of sexually transmitted disease in women Treatment of Mycoplasma genitalium. Observations from a Swedish STD clinic Treatment of acute pelvic inflammatory disease Mycoplasma genitalium: An Overlooked Sexually Transmitted Pathogen in Women?Management of Mycoplasma genitalium infections - can we hit a moving target?Mycoplasma genitalium infection: current treatment options, therapeutic failure, and resistance-associated mutations Gender analysis of moxifloxacin clinical trials Mycoplasma genitalium rapidly disseminates to the upper reproductive tracts and knees of female mice following vaginal inoculation.Prospective Evaluation of ResistancePlus MG, a New Multiplex Quantitative PCR Assay for Detection of Mycoplasma genitalium and Macrolide Resistance In vitro activity of the new fluoroketolide solithromycin (CEM-101) against macrolide-resistant and -susceptible Mycoplasma genitalium strains.'The difference in determinants of Chlamydia trachomatis and Mycoplasma genitalium in a sample of young Australian women'Mycoplasma genitalium infection is associated with microscopic signs of cervical inflammation in liquid cytology specimens.Recommendations and rationale for the treatment of pelvic inflammatory disease.Transmission and selection of macrolide resistant Mycoplasma genitalium infections detected by rapid high resolution melt analysis.The evolution of Mycoplasma genitalium.Recent perspectives in the diagnosis and evidence-based treatment of Mycoplasma genitalium.Sexually transmitted diseases treatment guidelines, 2015.Re-evaluating the treatment of nongonococcal urethritis: emphasizing emerging pathogens--a randomized clinical trial Mycoplasma genitalium: from Chrysalis to multicolored butterfly.Mycoplasma genitalium: should we treat and how?Mycoplasma genitalium: an emerging cause of pelvic inflammatory disease.Multiplex Assay for Simultaneous Detection of Mycoplasma genitalium and Macrolide Resistance Using PlexZyme and PlexPrime Technology.Mycoplasma genitalium presence, resistance and epidemiology in Greenland.Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections Standard treatment regimens for nongonococcal urethritis have similar but declining cure rates: a randomized controlled trial.Contribution of topoisomerase IV mutation to quinolone resistance in Mycoplasma genitalium.Mycoplasma genitalium infection activates cellular host defense and inflammation pathways in a 3-dimensional human endocervical epithelial cell model Fluoroquinolone and macrolide resistance-associated mutations in Mycoplasma genitalium Analysis identifying common and distinct sequences among Texas clinical strains of Mycoplasma genitalium.Bacterial Load in Daily Urine Samples of Patients Infected with Mycoplasma genitalium, Mutation Analysis, and Response to Treatment.Natural history of Mycoplasma genitalium infection in a cohort of female sex workers in Kampala, Uganda.Extensive variation and rapid shift of the MG192 sequence in Mycoplasma genitalium strains from patients with chronic infection.Characterization of the operon encoding the Holliday junction helicase RuvAB from Mycoplasma genitalium and its role in mgpB and mgpC gene variation.Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis.Advances in the Understanding and Treatment of Male Urethritis.2015 UK National Guideline on the management of non-gonococcal urethritis.Diagnosis and antimicrobial treatment of Mycoplasma genitalium infection: sobering thoughts.Mycoplasma genitalium in male urethritis: diagnosis and treatment in Japan.Mycoplasma genitalium: prevalence in men presenting with urethritis to a South Australian public sexual health clinic.2010 European guideline for the management of Chlamydia trachomatis infections.

P2860

Q21131426-293981A1-8B8C-492F-8ABB-BFCD4861A2E9 Q21133562-60A53DB3-B672-40C2-9693-E3C59E3FCCC3 Q21296776-E3F691F5-393B-4B04-AD74-1984C3F9119F Q26747053-EB38ECE2-7BC0-4CF1-92BA-0A878B013C9B Q26796722-26CC76A8-5542-4252-86CC-8E56010A0A5C Q27021073-3D7E8033-B501-4862-BAE5-57B197A4B779 Q28538319-E7DE786D-8FCD-4CB0-A189-C834FEBD9C9C Q33613919-2132A2E6-DFE4-44A4-947E-FFD664B27F91 Q33721540-C082E7B9-E452-44EC-9E5D-789003A36067 Q33797838-EE9917A5-EC04-4DB6-BE59-1219D9B96A3D Q33810064-A0A093DF-9B42-435A-B3E3-41F34E8D9689 Q33900022-B9D6EBD2-73F9-4179-BD10-47BB61E0D8DF Q34155769-630D8A00-0636-4671-91D2-00B0BB590F03 Q34245136-A5CB32C4-28E1-4E16-B2E9-EA21C4446683 Q34261217-BD07C466-4B50-4FDA-B971-188C1DE59AF9 Q34269050-8AB95C3B-7CA1-4026-BA28-F53B9337FFC4 Q34479272-F0068F43-5DE1-480E-B9B3-227CBD715704 Q35019879-AB77FE23-5145-4DE3-8CBE-6A93DA0F4669 Q35090137-D0633639-7E2B-4B14-AE64-89C8C1CE8BAA Q35542157-4BA778A2-CAA8-4784-95A4-513412A7F100 Q35659940-D24AAB80-4656-485E-8F1C-B2F8478EF656 Q36043585-74EA6E2E-6CE9-49B7-83B1-43C51AE05E0C Q36159575-8E937E37-4F56-4909-BBFD-6636DEC73EEA Q36393640-1F939AC8-E5DB-44EA-9DF7-39653F9A5895 Q36656274-721DD8A7-4CE5-4E5B-90B1-E1D882295F6A Q36757682-645C67AD-C976-44F0-85D0-254CE0E9EA9A Q36846270-A496395F-8353-4664-866A-1B76E8D9E435 Q36971250-6A14E18E-6F22-44B8-A5F2-C447EABC6706 Q37191589-9A06B5D1-5615-46F9-8113-57A968E2A9C8 Q37382490-240CA6B3-23C7-4042-AB5A-1DB813077962 Q37592110-69BE327D-68BE-4DFC-B6C7-44151B7F2291 Q37643907-6ECD3901-567D-4A48-84CB-268F98C7693F Q37713191-7A7AA8B3-385B-42A4-9F91-DD0E7EF0E970 Q37833830-9A554807-ED5E-4A6B-9EC3-C431098B8679 Q37838437-BDB9BD73-65F5-40A3-83D3-A522321D2C7F Q37840512-54600338-88CC-45CE-BDE0-E514D9FD5273 Q37844334-4F147908-9F6D-442C-A8AB-E4976C2F36CC Q37846695-40BD4833-D758-482E-9A18-4C9F31BE5E33 Q37847049-29E08841-9597-4E3C-B667-3A3FC0A0E665 Q37851690-3DCA1CDD-FFBC-4A9B-A5F8-809EBDACC12C

P2860

Persistence of Mycoplasma genitalium following azithromycin therapy

http://www.wikidata.org/entity/Q33382111

description

2008 nî lūn-bûn

@nan

2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Persistence of Mycoplasma genitalium following azithromycin therapy

@ast

Persistence of Mycoplasma genitalium following azithromycin therapy

@en

type

label

Persistence of Mycoplasma genitalium following azithromycin therapy

@ast

Persistence of Mycoplasma genitalium following azithromycin therapy

@en

prefLabel

Persistence of Mycoplasma genitalium following azithromycin therapy

@ast

Persistence of Mycoplasma genitalium following azithromycin therapy

@en

P1433

Q33382111-9F3B6A4D-77A3-4C22-99AF-CF63EAD1296E

P1476

Q33382111-B006921E-2E24-4BAC-9D5A-4CBC356F943F

P2093

Q33382111-0786F86B-24FB-4B1D-8CA4-AC434BD95703

Q33382111-FB579823-A419-4E37-B360-093E3D41DF03

P2860

Q33382111-024E0BC9-7E8F-42D5-8B7C-2761D2903347

Q33382111-082B1079-7A31-4D06-8C44-9C80649F2E29

Q33382111-110860E3-0349-4A08-956B-90AE5E92828B

Q33382111-14B3FA45-85E6-4BBA-976F-AFE0293E306D

Q33382111-192896BF-5A46-4249-99F1-DCE27E82D9A1

Q33382111-1A4A1C93-44A2-4F50-A351-9A705440D566

Q33382111-1B507256-7199-47C9-8E82-EAE9B5089D8C

Q33382111-540221FE-7E43-4D31-AA33-FB931EFC9A82

Q33382111-64354FC5-05A9-419B-9563-A6E6F680E84E

Q33382111-6AEA9DF4-65CE-49F5-953D-0C47C8643BF6

P304

Q33382111-325BBB25-55A3-49E7-8A6E-FE4B01F0CA28

P31

Q33382111-3C265486-2B5C-48B4-BC14-0E9617764C35

P356

Q33382111-B0FFA205-E75B-472F-90BD-44780005F075

P407

Q33382111-E2FE87A3-48DE-4214-92AC-51D6EC1E0F7E

P433

Q33382111-6EB31C14-C2C3-499F-8E24-B57E65EF8EC0

P478

Q33382111-BFB6B1E8-4DB5-4289-B5A8-B19A1522AAE2

P50

Q33382111-BED02ABE-ACC3-40DE-92CB-A02E8792290A

P577

Q33382111-28FED627-C3C0-43F5-A491-D9AD1576579A

P5875

Q33382111-85575AF1-8B4C-4ACD-87C4-DD52B79D5563

P698

Q33382111-38D3CA24-8140-4436-B099-D339534022A2

P921

Q33382111-4D4C392B-ED82-46D0-9A52-A22845D7262A

Q33382111-C47AA32B-3E72-46EC-AB0C-4BAE9EFA80A6

P932

Q33382111-25751BDE-4C33-4532-88EA-D68B50250DCE

P356

JOURNAL.PONE.0003618

P1433

P1476

Persistence of Mycoplasma genitalium following azithromycin therapy

@en

P2093

Catriona S Bradshaw

http://www.w3.org/2001/XMLSchema#string

Marcus Y Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Antibiotic susceptibility testing of Mycoplasma genitalium by TaqMan 5' nuclease real-time PCR.

Quantitative detection of Mycoplasma genitalium from first-pass urine of men with urethritis and asymptomatic men by real-time PCR

Sequence-based typing of Mycoplasma genitalium reveals sexual transmission.

Intrastrain heterogeneity of the mgpB gene in Mycoplasma genitalium is extensive in vitro and in vivo and suggests that variation is generated via recombination with repetitive chromosomal sequences.

Mycoplasma genitalium among women with nongonococcal, nonchlamydial pelvic inflammatory disease.

Tetracycline treatment does not eradicate Mycoplasma genitalium

Detection of Mycoplasma genitalium in women with laparoscopically diagnosed acute salpingitis.

Mycoplasma genitalium: the aetiological agent of urethritis and other sexually transmitted diseases.

Azithromycin failure in Mycoplasma genitalium urethritis.

Mycoplasma genitalium: an efficient strategy to generate genetic variation from a minimal genome.

P304

e3618

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003618

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Christopher K. Fairley

P577

2008-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23446361

http://www.w3.org/2001/XMLSchema#string

P698

18978939

http://www.w3.org/2001/XMLSchema#string

P921

Mycoplasma genitalium

P932

2572837

http://www.w3.org/2001/XMLSchema#string